In vitro susceptibility of community-acquired urinary tract pathogens to commonly used antimicrobial agents in spain: A comparative multicenter study (2002-2004)

Journal of Chemotherapy

Volumn 19, Issue 3, 2007, Pages 263-270

  Garcia Garcia M I ^a   Munoz Bellido J A ^a,b   Garcia Rodriguez J A ^a,b  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^b UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

E. coli; Epidemiology; Fosfomycin trometamol; Nitrofurantoin; Resistance; Spain; Urinary tact infection

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; CEFIXIME; CEFUROXIME AXETIL; CIPROFLOXACIN; COTRIMOXAZOLE; FOSFOMYCIN; NITROFURANTOIN; PIPEMIDIC ACID; TROMETAMOL;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; CONTROLLED STUDY; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; IN VITRO STUDY; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; NONHUMAN; PROTEUS MIRABILIS; PYURIA; SPAIN; STAPHYLOCOCCUS SAPROPHYTICUS; STREPTOCOCCUS AGALACTIAE; URINALYSIS; URINARY TRACT INFECTION; UROPATHOGENIC ESCHERICHIA COLI;

EID: 34447539566     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2007.19.3.263     Document Type: Article

References (20)

1. Hooton TM. Practice guidelines for urinary tract infections in the era of managed care. Int J Antimicrob Agents 1999; 11: 241-245.
2. Foxman B, Barlow R, d'Arcy H, Gillespie B, Sobel JD. Urinary tract infection: self-reported incidence and associated costs. Ann Epidemiol 2000; 10: 509-515.
3. Hooton TM, Stamm WE. Diagnosis and treatment of uncomplicated urinary tract infection. Infect Dis Clin North Am 1997; 11: 551-581.
4. Gupta K, Sahm DF, Mayfield D, Stamm WE. Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in women: a nationwide analysis. Clin Infect Dis 2001; 33: 89-94.
5. Gupta K, Scholes D, Stamm WE. Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women. JAMA 1999; 281:736-738.
6. European Association of Urology. The Management of Urinary and Male Genital Tract Infections (update 2006). http://www.uroweb.nl/files/ uploaded_files/guidelines/.
7. Warren JW, Abrutyn E, Hebel JR, Johnson JR, Schaeffer AJ, Stamm WE. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA). Clin Infect Dis. 1999; 29: 745-758.
8. National Committee for Clinical Laboratory Standards. (2002). Performance standards for antimicrobial susceptibility testing, 12th informational supplement. NCCLS document M100-S12. NCCLS, Villanova, PA, USA.
9. Dimitrov TS, Udo EE, Emara M, Awni F, Passadilla R. Etiology and antibiotic susceptibility patterns of community-acquired urinary tract infections in a Kuwait hospital. Med Princ Pract 2004; 13: 334-339.
10. nd year of the SENTRY antimicrobial surveillance program (1998). J Antimicrob Chemother 2000; 45: 295-303.
11. Kahlmeter G. An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO-SENS Project. J Antimicrob Chemother 2003; 51: 69-76.
12. Barrett SP, Savage MA, Rebec MP, Guyot A, Andrews N, Shrimpton SB. Antibiotic sensitivity of bacteria associated with community-acquired urinary tract infection in Britain. J Antimicrob Chemother 1999; 44:359-365.
13. Hryniewicz K, Szczypa K, Sulikowska A, Jankowski K, Betlejewska K, Hryniewicz W. Antibiotic susceptibility of bacterial strains isolated from urinary tract infections in Poland. J Antimicrob Chemother 2001; 47: 773-780.
14. Rodríguez Baño J, Navarro MD, Romero L, et al. Epidemiology and clinical features of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in non-hospitalized patients. J Clin Microbiol 2004; 42: 1089-1094.
15. Karlowsky JA, Kelly LJ, Thornsberry C, Jones ME, Sahm DF. Trends in antimicrobial resistance among urinary tract isolates of Escherichia coli from female outpatients in the United States. Antimicrob Agents Chemother 2002; 46: 2540-2545.
16. Alós JI, Serrano MG, Gómez Garcés JL, Perianes J. Antibiotic resistance of Escherichia coli from community-acquired urinary tract infections in relation to demographic and clinical data. Clin Microbiol Infect 2005; 11: 199-203.
17. Thomson KS, Sanders WE, Sanders CC. USA resistance patterns among UTI pathogens. J Antimicrob Chemother 1994; 33 (suppl A): 9-15
18. Acar JF, Goldstein FW. Trends in bacterial resistance to fluoroquinolones. Clin Infect Dis 1997; 24 (suppl 1): S67-S73.
19. Kahlmeter G, Menday P. Cross-resistance and associated resistance in 2478 Escherichia coli isolates from the Pan-European ECO-SENS Project surveying the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections. J Antimicrob Chemother 2003; 52: 128-131.
20. Kahlmeter G. Prevalence and antimicrobial susceptibility of pathogens in uncomplicated cystitis in Europe. The ECO.SENS study. Int J Antimicrob Agents. 2003;22 (Suppl 2):49-52.